These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 23039327

  • 1. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma.
    Jin J, Jin T, Quan M, Piao Y, Lin Z.
    Diagn Pathol; 2012 Oct 05; 7():135. PubMed ID: 23039327
    [Abstract] [Full Text] [Related]

  • 2. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z.
    Diagn Pathol; 2014 Mar 20; 9():67. PubMed ID: 24650035
    [Abstract] [Full Text] [Related]

  • 3. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J, Liu S, Xu Y, Wang C, Lin Z, Qin Y, Liu S.
    Exp Mol Pathol; 2015 Feb 20; 98(1):1-6. PubMed ID: 25445504
    [Abstract] [Full Text] [Related]

  • 4. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H, Cui A, Sun F, Zhang Y, Li Y, Li L, Lin Z.
    Exp Mol Pathol; 2014 Aug 20; 97(1):74-80. PubMed ID: 24866365
    [Abstract] [Full Text] [Related]

  • 5. Ezrin is associated with gastric cancer progression and prognosis.
    Li L, Wang YY, Zhao ZS, Ma J.
    Pathol Oncol Res; 2011 Dec 20; 17(4):909-15. PubMed ID: 21717114
    [Abstract] [Full Text] [Related]

  • 6. [Expression of Ezrin in gastric carcinoma and its significance].
    Shi RL, Li JF, Qu Y, Chen XH, Gu QL, Zhu ZG, Liu BY.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep 20; 9(5):433-5. PubMed ID: 17043968
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
    Hu X, Xin Y, Xiao Y, Zhao J.
    Pathol Oncol Res; 2014 Oct 20; 20(4):805-11. PubMed ID: 24643316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.
    Wang G, Gao J, Huang H, Tian Y, Xue L, Wang W, You W, Lian H, Duan X, Wu B, Wang M.
    BMC Cancer; 2013 May 29; 13():265. PubMed ID: 23718141
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer.
    Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, Han Y, Zhang W, Liang J, Wu K.
    Int J Cancer; 2014 Nov 15; 135(10):2329-37. PubMed ID: 24706505
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, Saito T, Kobayashi M, Hirohashi S.
    Cancer; 1993 Dec 01; 72(11):3179-84. PubMed ID: 7902202
    [Abstract] [Full Text] [Related]

  • 20. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y, Zhang T, Wang Q.
    Oncol Rep; 2013 Jul 01; 30(1):111-8. PubMed ID: 23612849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.